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The regulation of mucin secretion by airway goblet cells is poorly understood and the receptor-based
regulatory mechanisms have not been described in human airways. In the present study, we report that
extracellular triphosphate nucleotides regulate the rate of granule release from goblet cells in both normal
and cystic fibrosis (CF) airway epithelial explants. Explants isolated from nasal and tracheobronchial tis-
sues were mounted in perfusion chambers and the secretory activity was assessed by videomicroscopic
determination of degranulation in single goblet cells and by ELISA determination of mucins secreted into
the mucosal perfusate. Baseline degranulation was measured at 0.05 degranulation events (DE)/min. In
normal goblet cells, mucosal ATP (10-4 M, n = 17) induced a biphasic secretory response comprising
29.1 ± 4.9 DE during the first 5 min, with an initial rate of 118.2 ± 10.2 DE/min. Mucosal UTP
(10-4 M, n = 9) induced a similar response to ATP (initial rate: 89.2 ± 23.9 DE/min, 17.9 ± 5.1 DE
in 5 min), but mucosal 2-MeSATP was not an effective agonist (initial rate: 1.5 ± 1.4 DE/min, 2.3 ±
0.5 DE in 5 min). Determination ofmucins by ELISA confirmed that both ATP and UTP induced similar
secretory responses but that 2-MeSATP was not effective. In CF explants, mucosal UTP (10-4 M, n =
6) induced similar responses to those observed in normal tissues (initial rate: 82.5 ± 27.5 DE/min, 18.8 ±
4.1 DE in 5 min). We conclude that human nasal and tracheobronchial goblet cells are stimulated by
mucosal nucleotides, probably via a 5'-nucleotide receptor, and that this response is unaffected by CF.
Mucus secretion into the airway is a central component in
the process of mucociliary clearance, the respiratory defense
mechanism that traps inhaled foreign material in mucus and
removes it from the lung by the action of beating cilia. The
major determinants of the physical properties of mucus are
glycoproteins (mucins), which are traditionally considered
to be derived from two principal sources: mucous cells of
the submucosal glands and goblet cells situated in the epithe-
lium lining the airways. More recently, evidence has accrued
that similar glycoconjugates are released from the surface of
the airway epithelial cells in response to the action of various
proteases (1, 2). The presence of multiple sources of mucin
in the respiratory tract has hindered investigation of the regu-
lation of secretion from specific cell types, in particular
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goblet cells. Most studies of respiratory mucus secretion
have employed large airways that contain a greater volume
of submucosal glands than of goblet cells and have, there-
fore, provided information primarily about the regulation of
submucosal glands secretion (3). These studies have indi-
cated that submucosal glands in several species, including
human, are regulated by multiple systems including choliner-
gic, adrenergic, and nonadrenergic-noncholinergic (NANC)
pathways (4-7).
In contrast to submucosal glands, the regulation of secre-
tion from goblet cells is poorly understood, mainly due to
difficulty in collecting secretions from these cells without
contamination from glandular sources. Such studies are of
particular importance because in the small airways, which
are the principal site of involvement in obstructive airways
disease associated with hypersecretion, goblet cells are the
sole source of mucin. A morphometric study in intact guinea
pigs suggested that goblet cells are under neural control,
probably via cholinergic and NANC pathways (8). Addition-
ally, studies employing mucin-secreting primary cultures have
suggested that goblet cells are regulated by platelet-
activating factor (9) and adenosine-5'-triphosphate (ATP)
(10), in cat and hamster, respectively. Recently, this labora-
tory reported a technique to isolate and maintain intact
sheets of superficial epithelium in culture. Goblet cells in
these explant preparations were shown by videomicroscopy
to undergo degranulation in response to ATP (11).
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In this article, we report the first studies investigating the
regulation of secretion from goblet cells in explanted human
superficial nasal and tracheobronchial epithelium. The sec-
retory activity of goblet cells within the explants was moni-
tored both by direct visualization of the cells, using video-
microscopy, and by immunologic quantitation of secreted
mucins, using an enzyme-linked immunosorbent assay
(ELISA). These techniques have been employed to investi-
gate the secretory response of both normal and cystic fibrosis
(CF) goblet cells to activation by mucosal 5'-nucleotides.
Materials and Methods
Isolation and Culture of Airway Epithelial Explants
Inferior nasal tissues were obtained from six patients under-
going elective excision of turbinates for nasal obstruction.
Human tracheobronchial airways (distal trachea and first to
third generation bronchi) were dissected from tissues re-
moved from five patients (three with CF, one with bron-
chiolitis, and one with primary pulmonary hypertension) un-
dergoing lung transplantation at the University of North
Carolina and at 1 h postmortem from one patient with no ap-
parent lung disease. Although we are interested in investigat-
ing the effects of several 5'-nucleotides on goblet cell func-
tion in CF, the availability of such tissues is limiting.
Consequently, we chose to emphasize studies with UTP over
ATP on CF tissues because of its potentially greater ther-
apeutic value (see reference 27). All procedures were
reviewed and approved by the University of North Carolina
Committee for the Protection of Rights of Human Subjects.
Human airway epithelial explants were isolated and cul-
tured using minor modifications to the technique previously
described for canine tracheal epithelium (11). Briefly, tissues
were pinned out with the mucosal surface uppermost. A so-
lution containing collagenase (100 Mandl U/ml; Boehringer-
Mannheim, Indianapolis, IN) and dispase (1 U/ml, grade IT;
Boehringer-Mannheim) in phosphate-buffered saline (PBS)
was injected under the epithelium, and the tissue was bathed
in Joklik's MEM containing: I roM CaClz, 1 roM dithiothrei-
tol (Sigma Chemical Co., St. Louis, MO), 0.01 % DNAse 1
(Sigma), and hexokinase (1 U/ml; Boehringer-Mannheim).
After a 30-min incubation at 37°C in a 5 % COz incubator,
the epithelium was scraped from the tissue with a glass cov-
erslip and suspended in bathing medium. The suspended
sheet of epithelium was cut into 3- to 5-mm pieces, which
were explanted, mucosal surface uppermost, onto a syn-
thetic Vitrogen (Celtrix Pharmaceuticals, Santa Clara, CA)-
coated nitrocellulose substrate and allowed to attach by incu-
bation overnight at air:liquid interface in 5 % COz at 37°C.
The culture medium in contact with the basolateral surface
of the substrata was hormone-supplemented Ham's F12 con-
taining 3T3-conditioned medium, as described previously
(II), with the addition of hexokinase (I U/ml; Boehringer-
Mannheim). After overnight incubation, the explants were
washed by immersion in culture medium and returned to air-
liquid interface culture. The explants were maintained in this
configuration with daily changing of the medium until used,
usually within 2 to 3 days.
Perfusion and Measurement of Secretory Activity
For single-cell studies, airway epithelial explants were
mounted and perfused in Ussing chambers and, after a 30-
min equilibration period, the secretory activity was moni-
tored by videomicroscopy as previously described (II). In
experiments involving the immunologic measurement of se-
creted mucins, explants attached to nitrocellulose substrata
were mounted in Ussing chambers with a serosal volume of
80 ILl and a mucosal volume of 40 ILL The explants were sup-
ported serosally by a 3-mm filter (MF-Millipore) and were
held in place by a tissue-retaining ring possessing a 3-mm
opening into the mucosal half-chamber. The explant was
continuously perfused (100 ILl/min) on both sides with
medium (Ham's F12 to which had been added 15mM sodium
bicarbonate and 1 mM calcium chloride and the resulting
mixture readjusted to isotonicity), warmed to 37°C, and
equilibrated with 5% COz:95% Oz. Each experiment com-
menced with an initial 90-min equilibration period, which
was followed by a 30-min baseline period before agonist was
added to the mucosal perfusate. During both baseline and
agonist exposure periods, samples of mucosal perfusate were
collected at 5-min intervals by a fraction collector (Buchler
Instruments, Lenexa, KS) and stored at -20°C for subse-
quent analysis by mucin ELISA.
Mucin ELISA Procedure
An ELISA procedure was developed using the previously de-
scribed anti-mucin monoclonal antibody 17Bl (12, 13).
Samples (50 ILl) of perfusate or purified human mucin stan-
dard (0 to 50 ng) were bound to 96-well microtiter plates
(lmmulon 2; Dynatech Laboratories, Chantilly, VA) over-
night at 4°C. After washing in PBS containing 0.05% vol/vol
Tween 20 and 0.03% wt/vol bovine serum albumin (3 X 200
ILl), unbound sites were blocked by incubation with 200 ILl
of PBS containing 0.05 vol/vol Tween 20 and 3% wt/vol bo-
vine serum albumin (2 h, 22°C). The plates were washed as
above and incubated with 17Bl primary antibody (50 ILl,
2 h, 22°C) before undergoing further washes. The plates
were incubated (I h, 37°C) with 50 ILl goat anti-mouse im-
munoglobulins horseradish peroxidase conjugate (Cappel
Research Products, Durham, NC) and washed again as
above. The wells were developed by the addition of 150 ILl
0.01 % wt/vol 3'3'5'5'-tetramethylbenzidine in 0.1 M ace-
tate:citrate buffer, pH 6.0, containing 0.005 % hydrogen
peroxide. The reaction was stopped by the addition of
2.35 M sulfuric acid (50 ILl), and optical density at 450 om
measured in a Molecular Devices UVmax microplate reader.
Characterization of 17Bl Immunoreactivity
Immunohistochemical staining with 17Bl antibody was per-
formed on 5-mm sections of paraffin-embedded human bron-
chus. Sections were deparaffinized, rehydrated, and washed
with PBS, prior to blocking with 5 % goat serum for 20 min.
The blocked sections were incubated for 30 min at room
temperature with 17Bl antibody (1:500) or nonimmune se-
rum (5%) and washed 3 times in PBS. Binding of 17Bl was
visualized using gold-labeled goat anti-mouse immunoglob-
ulins and silver enhancement ("Auroprobe" and "Intense M";
Amersham, Arlington Heights, IL).
17Bl antibody was characterized further by Western blot-
ting of perfusate from human airways. Human tracheal epi-
thelial explants were mounted in chambers as described for
experiments involving immunologic measurement of mucin,
and the perfusate was collected. The perfusate and a sample
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of mucin standard were both lyophilized and dissolved in dis-
aggregation buffer (50 mM Tris, pH 6.8, with H3P04 , con-
taining 2 % sodium dodecyl sulfate [SDS] [wt/vol], 15%
glycerol [wt/vol], 2 % 2-mercaptoethanol [vol/vol], 1 mM
EDTA, and 0.02% bromophenol blue). Approximately 12 p,g
of perfusate material or mucin standard was loaded onto a
preformed 4 to 15% polyacrylamide gel (Bio-Rad Laborato-
ries, Richmond, CA) and electrophoresed in a running buffer
of 25 mM Tris glycine, pH 8.3, containing 0.2% SDS for 60
min at a constant current of 110 rnA. The gel was blotted
onto nitrocellulose membrane in 192 mM glycine, 25 mM
Tris, 20% methanol, pH 8.3, using a Bio-Rad Transblot cell
(35 V, 12 h, 15°C). The blotted membrane was washed in
Tris-buffered saline (TBS)-Tween solution (200 mM NaCI
and 0.1% [vol/vol] Tween 20 in 50 mM Tris, pH 7.4) and in-
cubated in the same solution containing 5% (wt/vol) Carna-
tion nonfat dry milk for 60 min at room temperature. 17Bl
antibody was diluted to 1:500 with TBS-Tween-milk and
incubated for 60 min at room temperature. The blot was
washed twice in TBS-Tweenand incubated with 2° antibody
(peroxidase-conjugated goat anti-mouse immunoglobulins)
for 60 min at room temperature. The blot was washed 3
times in TBS-Tween before being developed using an en-
hanced chemiluminescence kit (Amersham). Molecular
weight measurements were made during Bio-Rad high mo-
lecular weight standards run on the same gel and stained
with Coomassie Brilliant Blue.
Data Analysis
Video records obtained during single-cell studies were ana-
lyzed using a custom computer program that allowed the ob-
server to record the time of each individual degranulation
event within a particular cell (11). In addition, several of the
cells studied exhibited initial rates of degranulation that were
too rapid for manual analysis and in these cases the first min-
ute of the response was analyzed by the image-processing
system through the technique of temporal image subtraction.
This involved acquiring and storing images (two or four
frame average) from videotape at I-s intervals beginning 1 s
prior to the start of the response. These digital images were
then analyzed by subtracting sequential pairs, and the result-
ing images, showing no major detail other than the degranu-
lations that had occurred between the two time periods, were
displayed. The degranulations shown in each image were
then counted manually and recorded.
Data are presented as mean ± SEM, and statistical
significance between group means was judged by the Stu-
dent's t test at the 0.05 level of significance.
Materials
Tissue culture media were obtained from GIBCO BRL
(Gaithersburg, MD). Hormones for supplementing culture
media were obtained from Collaborative Research (Bedford,
MA). ATP and UTP were supplied by Boehringer-Mann-
heim, and 2-MeSATP was purchased from Research Bio-
chemicals Inc. (Natick, MA). All other chemicals were ob-
tained from Sigma.
Results
Airway epithelial explants visualized by videomicroscopy,
using differential interference contrast optics, appeared as an
intact epithelium whose surface was comprised of both
ciliated cells, possessing vigorously beating cilia, and goblet
cells that were identified by their nonciliated granular ap-
pearance (Figure 1). Goblet cells typically were densely
packed with several layers of granules that extended from the
apical pole several microns into the cell. In general, the
goblet cells were of a similar appearance to that previously
described for canine airway epithelial goblet cells, with the
exception that the granules of human goblet cells were rou-
tinely smaller than the 1.4-mm diameter reported for gran-
ules in canine airway epithelial explants (11). Owing to the
smaller size and tight packing of granules in human goblet
cells, it was difficult to resolve the boundaries of individual
Figure 1. Differential interfer-
ence contrast image of the apical
region of two adjacent goblet
cells in a human airwayepithelial
explant. An epithelialexplant was
mounted in a miniature Ussing
chamber and visualized by vi-
deomicroscopy. The image was
acquired as a 256-frame average
to reduce the effects of beating
cilia on image quality. Scale bar
is in mm.
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Figure 2. Response of a single human goblet cell
to mucosal ATP (10-4 M). An epithelial explant
was mounted and perfused in a miniature Ussing
chamber, and a goblet cell visualized by video-
microscopy. Secretory activity was determined by
recording the time at which individual degranula-
tions occurred within the cell. Data are expressed
as cumulative degranulations (squares) and rate of
degranulation (circles). Rates were calculated as 4-






























granules in direct Nomarski images, and granule diameters
were therefore determined from temporarily subtracted im-
ages (e.g., see Figure 3). This analysis yielded a mean di-
ameter for 50 granules in four cells from three explants of
1.0 ± 0.1 mm.
Exocytosis of individual granules from goblet cells in hu-
man explants was observed as the sudden disappearance of
agranule from the cell. In each experiment, the baseline rate
of degranulation was assessed over a 10- to 30-min period.
Of the 31 cells from nine non-CF patients studied, the
majority (21) exhibited no baseline degranulation events
(DE) and most of the remaining cells underwent fewer than
five events during the baseline period. From these data, ac-
cumulated over a total of 11.1 h of observation, a mean base-
line degranulation rate of 0.05 ± 0.02 DE/min/cell was cal-
culated. This value is the same as that calculated for canine
goblet cells under the same conditions (11). No significant
difference in baseline activity was observed between nasal
and tracheobronchial tissues. In CF explants, a mean base-
line degranulation rate of 0.14 ± 0.08 DE/min was calculated
(eight cells from three patients, 2 h of observation), a value
that is not significantlydifferent from that observed in non-Cf
explants.
The response of goblet cells to a mucosal challenge with
ATP (10-4 M) was studied in 17 cells in eight non-CF ex-
plants isolated from eight tissues (six nasal, two tracheo-
bronchial), a typical response of a single cell being shown
in Figure 2. Early in the baseline period, three degranula-
tions were observed; however, the cell was then quiescent for
19 min prior to the switch to mucosal ATP. This maneuver
induced an almost immediate increase in secretion, with
nearly 70 degranulations observed during the 20 min that the
cell was exposed to ATP. The response exhibited a biphasic
pattern comprising an initial burst of very rapid degranula-
tion with a rate in excess of 300 DE/min, after which the rate
progressively slowed until a stable rate of approximately 0.4
DE/min was achieved. The rapid rate of exocytosis exhibited
by goblet cells during the early stages of the response to
mucosal ATP can be seen in Figure 3, which depicts the im-
age subtraction analysis of the initial seconds of such a re-
sponse. The images shown were acquired by subtraction of
the image obtained 1 s prior to the response from images ob-
tained at l-s intervals during the first 5 s of the response. The
first panel indicates that just prior to the response no degran-
ulations occurred; however, in the next image (t = 1 s), five
degranulations, seen as bright spots in the image, are appar-
ent. Images 2 through 5 reveal an additional four, four, two,
and one events during each of the subsequent seconds,
respectively, indicating that the cell underwent a total of 16
degranulations during the first 5 s of the response to muco-
sal ATP.
Comparison of responses obtained with non-CF nasal
and tracheobronchial tissues indicated that there was no
significant difference in either the number of degranulations
during the first 5 min of the response (28.0 ± 5.06 DE and
20.6 ± 3.4 DE, respectively) or the initial rate (68.1 ± 26.5
DE/min and 95.4 ± 30.12 DE/min, respectively). Conse-
quently, the data from both groups were combined for analy-
sis of the responses to different nucleotides. Table 1 de-
scribes the responses of non-CF goblet cells to a mucosal
challenge with the nucleotides ATP, UTP, or 2-MeSATP,and
CF goblet cells challenged with UTP. All nucleotides were
used at 10-4 M, a concentration that has been found to in-
duce near maximal responses in ion transport and inositol
phosphate production in human airway epithelia (14, 15). All
cells challenged with ATP or UTP responded by degranula-
tion. The magnitude of the response was variable, however,
ranging from two to 84 degranulations during the first 5 min
of the response. Responses to ATP or UTP were compara-
ble, both in terms of the number of degranulations and the
initial rate at which these occurred. In contrast to the striking
responses obtained with ATP and UTP, the P2Y-purinergic
receptor agonist 2-MeSATP failed to induce similar rates of
degranulation, the number of degranulations being only 5 to
10% of that achieved with ATP or UTP. The response of
goblet cells in CF explants challenged with mucosal UTP
was similar to that observed in non-CF cells, both in terms
of the initial rate of degranulation and the overall extent of
degranulation. In addition, both cells in a CF explant chal-
lenged with mucosal ATP responded robustly (71 and 62 DE
in the initial 5 min), a pattern of degranulation that is similar
to the ATP response in non-CF cells.
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Figure 3. Analysis of the initial response shown in Figure 2, by image subtraction. Images were obtained by subtracting an image (two-
frame average) obtained 2 s prior to the response from similar images obtained at I-s intervals for the first 5 s of the response (panels
o through 5). The displayed results show individual degranulations as bright spots.
As shown in Figure 4, the stimulation of goblet cell de-
granulation by nucleotides was associated with an increase
in the release of mucin glycoprotein as measured by ELISA.
In each experiment, nucleotide (10-4 M) was perfused onto
the tissue either mucosally or bilaterally after a 30-min base-
line period and, because no difference between mucosal and
bilateral response was observed, Figure 4 depicts the com-
bined data. As was seen with the single-cell studies, both
ATP and UTP were capable of inducing the secretion of mu-
cin from the epithelial explants and appeared to possess a
similar efficacy. Moreover, 2-MeSATP did not result in in-
creased mucin secretion, a finding that is in agreement with
the single-cell studies (Table 1). In contrast to the rapid onset
of degranulation in response to ATP and UTP observed in
single cells, the response to these agents in whole explants
was maximal 10 min after the addition of nucleotide to the
perfusate. This, however, is probably a reflection of the
longer washout time of the perfusion system used in the whole
explant studies (4 min versus 30 s) and the time required for
dispersion of the freshly secreted mucin into the perfusion
medium.
In whole explant studies, ATP or UTP induced a 2-fold
increase in secretion, which is considerably smaller than the
greater than 100-fold increase in degranulation obtained in
TABLE 1
Response of human goblet cells to mucosal nucleotides (10-4 M)*
ATP UTP UTP 2-MeSATP
(Normal) (Normal) (CF) (Normal)
Number of cells (n) 17 9 6 11
Degranulations during initial
5 min (DE/cell) 29.1 ± 4.9 17.9 ± 5.1 18.8 ± 4.1 2.3 ± O.5t
Initial rate (DE/min) 118.2 ± 10.2 89.2 ± 23.9 82.5 ± 27.5 1.5 ± l.4t
Definition of abbreviation: DE = degranulation event.
* For details of the experimental procedure, see Figure 2.
t Different from ATP (P < 0.001).
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Time (min)
Figure 4. Effect of nucleotides (10-4 M) on secretion from non-
CF human airway epithelial explants. Explants were mounted in
Ussing chambers and continuously perfused. Samples of mucosal
perfusate (collected over 5 min) were analyzed for mucin content
by ELISA. Nucleotide (ATP: n = 8, UTP: n = 5, 2-MeSATP: n =






















single-cell studies. This discrepancy is probably due to dif-
ferences in the measured level of baseline secretion which
was very low in the case of degranulation (0.05 DE/min) and
high in the case of ELISA studies (1.30 ± 0.15 Ilg/ml). To
investigate the origin of this high baseline, the antibody used
in the ELISA (17Bl) was characterized further by immuno-
histochemistry and Western blotting of the perfusate (Figure
5). Antibody staining of human bronchial sections (Figures
5A and 5B) shows that antibody 17BI stained the mucin
granules within individual goblet cells of the superficial epi-
thelium. In addition, however, intense staining of the apical
surface of ciliated cells was observed. Western blotting with
antibody 17Bl (Figure 5C) revealed that the antibody stained
the mucin standard and that this was predominantly located
at the origin of the gel. Nevertheless, considerable smearing
down to an M, of approximately 200 kD was observed,
probably due to the fact that this standard is a reduced mucin
purified from CF sputum and hence would be expected to
contain significant levels of highly degraded mucin. In con-
trast, immunoreactivity of the perfusate showed a tight band
at the origin probably representing undegraded mucins. Fur-
thermore, a broad band of heterogeneous staining was ob-
served in the range of M, 50 to 150 kD, which is below that
of the most degraded mucins present in the mucin standard.




Figure 5. Characterization of 17Bl monoclonal antibody. Sec-
tions of human bronchus (5 mm) were stained with 17Bl antibody
(A) or non-immune serum (B) and developed with gold-labeled 2°
antibody as described in MATERIALS AND METHODS. Bar = 10 mm.
For Western blotting with 17Bl (C), lyophilized perfusate from ex-
plants mounted in chambers of mucin standard was electrophoresed
on a 4 to 15% gradient SDS-PAGEgel and blotted onto nitrocellu-
lose. The blotted membrane was blocked and incubated with 17Bl
antibody (1:500) followed by peroxidase-conjugated secondary an-
tibody. Bound antibody was detected by the chemiluminescence
method.
Discussion
The presence of multiple sources of airway mucin in intact
animals and whole airway preparations has resulted in
studies employing these systems providing little specific in-
formation about the regulation of goblet cells. More recently,
the availability of airway epithelial cell cultures containing
goblet-like cells (9, 11, 16) has provided the opportunity for
studies of this cell type in nonhuman species. Several agents
have been reported to regulate mucin secretion from goblet
cells, including elastase (17), cholinergic and possibly ad-
renergic stimuli (8), tachykinins (18), platelet-activating fac-
tor (9), and purinergic compounds (10, 11). The possibility
of species variability in expression of regulatory pathways in
epithelia, however, requires that stimuli be assessed directly
in human airways. Unfortunately, difficulties in the culture
of well-differentiated goblet cells has resulted in a lack of
data regarding the regulation of goblet cells in humans.
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The results presented here indicate clearly that the tech-
nique of isolating and explanting intact sheets of superficial
epithelium as described previously for the study of goblet
cells in canine trachea (11) is also applicable to human air-
ways. This explant preparation has the advantage over the
mucin-producing primary cultures of human airway epithe-
lium that cellular differentiation occurs through the normal
processes in the host organism. Furthermore, the lack of
alteration in morphology (11) during the isolation and explan-
tation procedures suggests that tissue damage is minimal, in-
creasing the likelihood that the physiologic processes ex-
hibited by the explants will accurately model those of the
native tissue.
In addition, this study extends the previous work in canine
tissue (11) by indicating that the degranulation observed in
single-cell studies is associated with the release of immuno-
logically identifiable mucins. The discrepancy in baseline
levels of secretion between single-cell studies and those in
whole explants suggests that the 17Bl antibody is identifying
other material, in addition to mucins released by degranula-
tion. This is supported by the characterization of 17Bl im-
munoreactivity (Figure 5). It is clear that in addition to the
mucin granules of goblet cells antibody 17Bl strongly recog-
nizes an epitope on the apical surface of ciliated cells. This
observation is supported by a report from Wu and co-workers
in which, in addition to staining of goblet cells, some stain-
ing of the epithelial surface with 17Bl is visible (19, Figure
6). The Western blot of perfusate indicates that in addition
to the presence of a band at the origin, representing high mo-
lecular weight mucins, there is a heterogeneous signal of
M, 50 to 150 kD. The identity of this low molecular weight
material is not clear; however, it is unlikely to be proteolyti-
cally degraded mucins since this material is smaller than
glycosylated regions (T-domains), which are the smallest
units produced experimentally by extensive proteolytic
digestion ofmucins (20, 21). In addition, the presence oflow
molecular weight immunoreactivity in the perfusate indi-
cates that nonmucin material that reacts with the antibody is
released from the explants. Thus, it seems probable that the
high baseline in whole explants is probably due to the release
of nonmucin components that cross react with antibody
17Bl.
This study indicates that luminal triphosphate nucleotides
are highly effective regulators of mucin granule release in
human goblet cells. Both the biphasic pattern of degranula-
tion and the magnitude of response induced by mucosal ATP
are similar to those previously reported for canine epithelial
explants (11), suggesting that ATP is acting in both tissues
through the same mechanism. Previous studies in hamster
(10) and dog (11) have indicated that the action of ATP on
goblet cells is mediated via Prpurinergic receptors on the
cell surface, although in neither study was it clear which
specific subclass of receptor was involved. From the canine
study, it seems probable that the dominant response is medi-
ated via a single class of ATP-specific receptors on the apical
surface, while the basolateral surface may be populated with
both ATP receptors and other purinergic receptors.
The present study focuses on the responses to apically
applied purinergic compounds mediated through a Ps-puri-
nergic receptor. Based on the relative potencies of various
agents, four subclasses of P2-purinoreceptors (P2X , P2Y , Pzr,
and P2Z) have been proposed (15, 22, 23). In addition, a 5'-
nucleotide receptor sensitive to both purine (ATP) and
pyrimidine (UTP) triphosphate nucleotides has been de-
scribed in several tissues including human airway epithelial
cells (15,24). In the present study, the equal potency of ATP
and UTP in stimulating secretion is consistent with the in-
volvement of the 5'-nucleotide receptor. Furthermore, the
activity of UTP suggests that the P2Y receptor is not in-
volved since this receptor has been reported to be unaffected
by UTP (24), a conclusion further supported by the failure
of the potent P2Y receptor agonist 2-MeSATP to induce
secretion. It is also clear that the ADP-sensitive Pzr recep-
tor is not responsible for the effect seen here since ATP,
which caused a striking increase in secretion in the human
tissues, has been reported to be an antagonist for this recep-
tor (23). At present, the activity of UTP at the P2X or P2Z
receptor is unknown and hence the involvement of one of
these receptors in the secretory response of goblet cells can-
not be excluded. This seems unlikely, however, since
mucosal ADP, which is more potent than ATP for the P2X
receptor, has been reported to be ineffective at inducing de-
granulation of canine goblet cells (11). Furthermore, studies
in this laboratory suggest that the half-maximal dose (ECso)
for ATP in canine tissues is 3 to 4 mM (unpublished observa-
tion), a concentration much lower than the 50 mM that has
been reported to be the minimum active concentration for
the P2Z receptor (23). Hence, the present study, in combi-
nation with similar studies in canine tissues, suggests that lu-
minal triphosphate nucleotides exert their effect on human
goblet cells via the 5'-nucleotide receptor.
The results obtained from an ATP challenge of a CF ex-
plant and those from studies of UTP on CF and normal tis-
sues (Table 1) indicate that the secretory response of goblet
cells to nucleotides is intact in CF. Recently, it has been sug-
gested that CF cells may exhibit impaired cAMP-regulated
membrane recycling, including exocytosis (25). The compe-
tent exocytosis observed in CF cells in the present study sug-
gests that the response to nucleotides is mediated by a cAMP-
independent pathway, possibly Ca2+ , since ion transport
studies in airway epithelia have shown this pathway to be
unaffected by CF (26). This is supported by studies in
CF/T43 cells which measured inositol phosphate production
in response to ATP and UTP, implicating linkage of the
5'-nucleotide receptor to a Ca2+-mediated pathway (15). In
addition, direct Ca2+ measurements have shown that both
normal and CF airway epithelial cells respond to ATP and
UTP with increases in intracellular Ca2+ (14).
The ability of ATP and UTP to stimulate mucin secretion
in both normal and CF cells is of particular interest in view
of the recent finding that these agents are capable of inducing
chloride secretion in the CF airway and may therefore be of
therapeutic value (27). The intact response of CF tissues to
nucleotides reported here suggests that aerosolized nucleo-
tides may induce an increase in mucus secretion into the CF
airway, potentially reducing the beneficial effect of any in-
crease in chloride and fluid secretion. It is possible, however,
that due to the hypersecretory nature of CF, the resting level
of goblet cell secretion in CF airways in situ is considerably
higher than the baseline rate measured in vitro. If this is the
case, then any increase in mucin secretion caused by nucleo-
tide therapy would be smaller than that observed in this study
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and may be compensated for by a larger increase in chloride
and fluid secretion. Under these circumstances, treatment of
CF lung disease with nucleotides may have an overall bene-
ficial effect.
The importance of luminal nucleotide-regulated goblet
cell secretion in vivo is not clear. Although significant levels
of ATP have been found in rat bronchoalveolar lavage (28),
the concentration of ATP in the airway lumen and whether
this is altered in normal and pathologic situations is not
known. There are several potential sources for ATP in the
airway, including nerve terminals releasing ATP as a neu-
rotransmitter, and inflammatory and epithelial cells releas-
ing ATP as a result of damage and cell death or in regulated
processes. The contribution of cellular sources to ATP levels
in the airway could be of particular significance in pathologic
situations associated with inflammation and cell damage.
Furthermore, it is interesting to note that ATP has been
reported to be capable of stimulating the other components
of the mucociliary clearance system, ciliary beat (29), and
ion and fluid transport (14). In combination, these findings
suggest that the secretory response of goblet cells to ATP
may be part of a coordinated action of ATP to increase
mucociliary clearance from the airway. Thus, ATP is a
potentially important agonist in both normal homeostasis
and the response to disease.
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